Until Labs has raised $58M in Series A funding to advance organ cryopreservation technology, led by Founders Fund with Lux Capital and Field Ventures participating.
Amount Raised
$58 Million
Round Type
Series A
San FranciscoManufacturingBiotechnologyHealth CareresearchInvestors
Description
Until Labs secures $58M in Series A funding to grow its multidisciplinary team aimed at pioneering organ-scale reversible cryopreservation. The technology will help preserve donor organs for indefinite storage, addressing challenges in organ transplantation. Founded with the vision of enabling whole-body medical hibernation, Until Labs focuses on improving organ quality post-cryopreservation. This funding supports crucial advances in their research and development.
Who to call at Until Labs, and when
A new round usually means Until Labs is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Until Labs raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Until Labs, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Until Labs. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Until Labs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansUntil Labs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.